ADRX

ADARx Pharmaceuticals, Inc.

Healthcare · Biotechnology

$251.50 sample

-1.00 (-0.40%) 1D

Market cap

$995.5B

Price as of

2026-10-03

Latest filing

8-K · 2026-09-23

Alerts

8

Price$251.50 +5.76% 3M daily closessample

257.60229.93

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 30INSInsider sell: EVP, Operations
Sep 23SEC8-K filed: material event
Sep 15SECForm 144 filed
Sep 10SEC10-Q filed
Sep 01INSInsider buy: 10% owner
Aug 21SECDEF 14A filed
Aug 17SEC8-K filed: material event
Aug 07INSInsider buy: 10% owner

Sign up to see the real ADRX record →

Company facts

SEC EDGAR registration

Name: ADARx Pharmaceuticals, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +11sample, -100 to +100
Reporting currency: USD

Who is positioning in ADRX

sample

Insiders: 32 insider transactions over 90 days, net selling, $64.9M
Congress: 2 members traded over 90 days
Institutions · 13F: 30 funds hold $16.9B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$54.2B +14.7% y/y

Q4 2024Q3 2026

Inventory$32.6B +16.1% y/y

Q4 2024Q3 2026

Accounts receivable$25.2B +16.5% y/y

Q4 2024Q3 2026

Total debt$65.8B +18.3% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $271.5B +1.7% 3M
Sample peer B: $570.0B +13.6% 3M
Sample peer C: $872.3B +5.0% 3M
Sample peer D: $491.0B +12.7% 3M
Sample peer E: $476.1B -0.3% 3M